ClinConnect ClinConnect Logo
Search / Trial NCT04914143

the Effect of Broken Ganoderma Lucidum Spore Powder on Quality of Life and Immune Function in Patients With Diffuse Large B-cell Lymphoma After Chemotherapy

Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Jun 3, 2021

Trial Information

Current as of June 08, 2025

Unknown status

Keywords

Broken Ganoderma Lucidum Spore Powder

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diffuse large B-cell lymphoma,NOS
  • all patients were diagnosed for the first time
  • between 18-75 years old, male and female
  • ECoG 0-3 ,the expected survival was more than 6 months
  • the pregnancy test of women of childbearing age was negative; Male and female patients should agree to take effective contraceptive measures during the treatment period and one year of follow-up;
  • sign the informed consent before the test screening
  • Exclusion Criteria:
  • those who are known to be allergic to the study drug or its related components; Or allergic patients
  • uncontrolled psychosis
  • participating in other trials at the same time, and using experimental drugs that may affect the efficacy and safety evaluation
  • impairment of liver and kidney function
  • HIV antibody positive;
  • HBsAg positive hepatitis B carriers and confirmed hepatitis B and C patients;
  • pregnant or lactating women and patients who do not agree to take effective contraceptive measures;
  • the patient is unable to swallow the capsule or has a disease or condition that seriously affects the gastrointestinal function;

About Second Affiliated Hospital, School Of Medicine, Zhejiang University

The Second Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing healthcare through innovative medical practices and rigorous scientific inquiry. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, the hospital is committed to conducting high-quality clinical trials that address critical health challenges. As an integral part of Zhejiang University, the hospital leverages academic expertise and cutting-edge technology to foster collaboration in research, education, and patient care, ultimately aiming to improve patient outcomes and contribute to the global medical community.

Locations

Hangzhou, Zhejiang, China

Patients applied

0 patients applied

Trial Officials

yun liang

Principal Investigator

2ndAffiliated Hospital, School of Medicine, Zhejiang University, China

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials